Concepedia

Publication | Closed Access

Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age

DOI

125

Citations

23

References

2010

Year

Matthew D. Snape, Chaam L. Klinger, Elvis D. Daniels, Tessa M. John, Helen Layton, Llinos Rollinson, S. Pestridge, Sandra Dymond, Eva Galiza, S. Tansey,
The Pediatric Infectious Disease Journal

Abstract

A 2-, 4-, and 12-month course of PCV13 was immunogenic for all 13 vaccine serotypes and was well tolerated.

References

YearCitations

Page 1